ArticlePloS one2022

In silico analysis of potential off-target sites to gene editing for Mucopolysaccharidosis type I using the CRISPR/Cas9 system: Implications for population-specific treatments.

Paola Carneiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.